Tim C. Hardman

Richmond, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID19: a multicenter, randomized, double-blind, placebo-controlled study.

Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID19: a multicenter, randomized, double-blind, placebo-controlled study.

Journal: Expert review of respiratory medicine
Published: June 09, 2026

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.

Journal: F1000Research
Published: November 01, 2022

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.

Journal: Allergy
Published: January 17, 2022

How to Interpret an Investigator's Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum.

How to Interpret an Investigator's Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum.

Journal: Therapeutic innovation & regulatory science
Published: May 07, 2020

The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study.

The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study.

Journal: Drugs in context
Published: January 10, 2020

European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development-Be Prepared.

European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development-Be Prepared.

Journal: Frontiers in pharmacology
Published: September 10, 2019

The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum.

The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum.

Journal: Frontiers in pharmacology
Published: March 12, 2019

Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus.

Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus.

Journal: Journal of cachexia, sarcopenia and muscle
Published: January 09, 2019

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.

Journal: Trials
Published: February 24, 2017

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).

Journal: Thorax
Published: May 28, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026